Skip to main content

Galmed Pharmaceuticals Ltd.

EOCN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001595353

No open-market purchases or sales by Galmed Pharmaceuticals Ltd. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $85.9K in total; no superinvestor holds it.

Members of Congress who traded EOCN

No member of Congress has reported a trade in Galmed Pharmaceuticals Ltd. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.